Publication Name	World Journal of Rheumatology
Manuscript ID	9948
Country	Italy

Received	2014-03-06 09:24
Peer-Review Started	2014-03-06 23:25
To Make the First Decision	2014-03-26 15:24
Return for Revision	2014-04-04 07:19
Revised
Second Decision	2014-05-29 08:57
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-05-29 09:47
Articles in Press	2014-05-29 09:47
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-07-01 12:15
Publish the Manuscript Online	2014-07-10 11:39

ISSN	2220-3214 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Rheumatology
Manuscript Type	Retrospective Study
Article Title	TNF-α inhibitors and tocilizumab do not influence hepatic steatosis in patients with rheumatoid arthritis
Manuscript Source	Unsolicited Manuscript
All Author List	Paola Sessa, Matteo Nicola Dario Di Minno, Rosella Tirri, Carmine Finelli, Gabriele Valentini and Giovanni Tarantino
Funding Agency and Grant Number
Corresponding Author	Giovanni Tarantino, MD, Professor, Department of Clinical Medicine and Surgery, Federico Ⅱ University Medical School of Naples, Via Sergio Pansini, 5, 80131 Naples, Italy. tarantin@unina.it
Key Words	Steatosis; Rheumatoid arthritis; Biological agents
Core Tip	Tumor necrosis factor (TNF)-α and interleukin-6 are not only key-cytokines in the pathogenesis of rheumatoid arthritis (RA) but can also inducing hepatic steatosis (HS) in general population. RA patients treated with Methotrexate (MTX) or TNF-α inhibitors or Tocilizumab underwent an abdominal ultrasonography for the assessment of presence of HS and the evaluation of its grade. At baseline and after 12 mo no difference was detected either in the prevalence of HS or in that of its distinct grades between the patients treated with MTX or TNF-αinhibitors or Tocilizumab.
Publish Date	2014-07-10 11:39
Citation	Sessa P, Di Minno MND, Tirri R, Finelli C, Valentini G, Tarantino G. TNF-α inhibitors and tocilizumab do not influence hepatic steatosis in patients with rheumatoid arthritis. World J Rheumatol 2014; 4(1): 1-5
URL	http://www.wjgnet.com/2220-3214/full/v4/i1/1.htm
DOI	http://dx.doi.org/10.5499/wjr.v4.i1.1

Full Article (PDF)	WJR-4-1.pdf
Full Article (Word)	WJR-4-1.doc
Manuscript File	9948-Review.doc
Answering Reviewers	9948-Answering reviewers.pdf
Copyright License Agreement	9948-Copyright assignment.pdf
Peer-review Report	9948-Peer review(s).pdf
Scientific Misconduct Check	9948-CrossCheck.jpg
Scientific Editor Work List	9948-Scientific editor work list.pdf